Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mylan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mylan's 2012 sales performance.

Mylan Inc.

Pfizer raises forecast following growth of biopharma business

Pfizer raises forecast following growth of biopharma business It will also likely see growth following its merger with generics company Mylan, which was announced in July and expected to be completed by next year.

Why Marry?

Why Marry? Abbvie, Mylan, Allergan and Pfizer. ... A similar argument can be seen in Pfizer’s combination of its Upjohn business with Mylan.

Pfizer goes big on gene therapy with $500m facility spend

Pfizer goes big on gene therapy with $500m facility spend Meanwhile, Pfizer has also been stripping out businesses it sees as lying outside its core focus of innovative medicines, selling off its older and generic drugs to Mylan earlier this year

Sanofi patent case win holds off generic rivals for key cancer drug

Sanofi patent case win holds off generic rivals for key cancer drug Companies including Actavis and Mylan have received tentative US Food and Drug Administration (FDA) approvals for copies of Jevtana in recent years.

US politicians round on generics firms for blocking drug pricing probe

US politicians round on generics firms for blocking drug pricing probe Renews focus on increases in generic drug prices. US politicians are going after Heritage Pharmaceuticals, Mylan and Teva Pharmaceutical Industries for allegedly stonewalling an earlier effort to gather drug pricing information. ... The lawsuit has led

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...